{"title":"[Benefit of Intraoperative Mannitol Use during Endoscopic Surgery for Intracerebral Hemorrhage].","authors":"Tatsuya Kida, Atsuhiko Kubo, Teisei Kobashi, Masakazu Sumitomo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Endoscopic hematoma evacuation is an established treatment option for patients with intra- cerebral hemorrhage (ICH). The purpose of this study is to investigate the benefit of mannitol use during en- doscopic hematoma evacuation.</p><p><strong>Methods: </strong>One hundred patients with ICH treated by endoscopic surgery from June 2009 to November 2014 were retrospectively reviewed. We divided them into mannitol administered group (n=19) and non- administered group (n=81).</p><p><strong>Results: </strong>As for the patient background, surgical time, amount of intraoperative bleeding, residual hema- toma, re-operation and postoperative 30-day mortality, no significant differences were found between the two groups.</p><p><strong>Conclusions: </strong>There was no clear clinical benefit of intraoperative mannitol use during endoscopic surgery for ICH.</p>","PeriodicalId":18254,"journal":{"name":"Masui. The Japanese journal of anesthesiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Masui. The Japanese journal of anesthesiology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Endoscopic hematoma evacuation is an established treatment option for patients with intra- cerebral hemorrhage (ICH). The purpose of this study is to investigate the benefit of mannitol use during en- doscopic hematoma evacuation.
Methods: One hundred patients with ICH treated by endoscopic surgery from June 2009 to November 2014 were retrospectively reviewed. We divided them into mannitol administered group (n=19) and non- administered group (n=81).
Results: As for the patient background, surgical time, amount of intraoperative bleeding, residual hema- toma, re-operation and postoperative 30-day mortality, no significant differences were found between the two groups.
Conclusions: There was no clear clinical benefit of intraoperative mannitol use during endoscopic surgery for ICH.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
